| Literature DB >> 35415509 |
Christopher Vannabouathong1, Pei Li2, Varun Srikanth2, Minzhi Chen2, Mohit Bhandari3, Sanjeev Kakar4.
Abstract
Purpose: Metacarpal neck fractures may perform well without operative intervention, but the current literature on this topic is fragmented and guidance on managing these injuries needs further refinement. We conducted a systematic review and network meta-analysis to provide a comprehensive evaluation of the various treatments available for these injuries.Entities:
Keywords: Fracture; Meta-analysis; Metacarpal neck; Systematic review
Year: 2020 PMID: 35415509 PMCID: PMC8991433 DOI: 10.1016/j.jhsg.2020.04.005
Source DB: PubMed Journal: J Hand Surg Glob Online ISSN: 2589-5141
Inclusion and Exclusion Criteria
| Inclusion Criteria | Exclusion Criteria |
|---|---|
| Metacarpal fracture of any digit | Study focused on pediatric or adolescent patient population |
Figure 1Flow diagram of included studies.
Characteristics of Included Studies
| Author, Year | Location of Study | Study Design | Fracture Location | Sample Size | Treatments Evaluated | Length of Study Follow-Up | Age, y | Gender (% Male) |
|---|---|---|---|---|---|---|---|---|
| Cepni et al, 2016 | Turkey | Randomized trial | Fifth MC; neck fracture | 24 | AIMP | 45 d | Mean: 28 (range, 18–46) | 100 |
| Placement of orthosis | Mean: 28 (range, 18–46) | 100 | ||||||
| Facca et al, 2010 | France | Observational cohort | Fifth MC; neck fracture | 38 | AIMP | Mean: 3 mo (range, 2–14 mo) | Mean: 35 (range, 18–73) | 85 |
| Plating | Mean: 5 mo (range, 2–14 mo) | Mean: 30 (range, 18–53) | 94 | |||||
| Fujitani et al, 2012 | Japan | Observational cohort | Any MC; neck fracture | 30 | AIMP | 12 mo | Mean: 28 (range, 16–59) | 87 |
| Plating | Mean: 33 (range, 17–53) | 87 | ||||||
| Galal and Safwat, 2017 | Egypt | Randomized trial | Fifth MC; neck fracture | 60 | AIMP | 12 mo | Mean: 32 | NR |
| TP | Mean: 32 | NR | ||||||
| Kaynak et al, 2019 | Turkey | Observational cohort | Fifth MC; neck fracture | 40 | Placement of orthosis | 6 mo | Mean: 28 (range, 18–58) | 94 |
| Functional bracing | Mean: 30 (range, 18–43) | 100 | ||||||
| Kim and Kim, 2015 | South Korea | Randomized trial | Fifth MC; neck fracture | 46 | AIMP | 6 mo | Mean: 31 (range, 18–53) | 100 |
| RIMP | Mean: 32 (range, 19–54) | 100 | ||||||
| Schadel-Hopfner et al, 2007 | Germany | Observational cohort | Fifth MC; neck fracture | 30 | AIMP | Median: 17 mo (range, 6–34 mo) | Median: 26 (range, 15–46) | 100 |
| Retrograde cross-pinning | Median: 18 mo (range, 12–41 mo) | Median: 25 (range, 16–52) | 93 | |||||
| Sletten et al, 2015 | Norway | Randomized trial | Fifth MC; neck fracture | 81 | AIMP | 12 mo | Median: 25 (range, 18–68) | 92 |
| BS | Median: 29 (range, 18–67) | 91 | ||||||
| Strub et al, 2010 | Switzerland | Randomized trial | Fifth MC; neck fracture | 40 | AIMP | 12 mo | Mean: 28 (range, 20–44) | 95 |
| FB | Mean: 32 (range, 21–70) | 90 | ||||||
| van Aaken et al, 2016 | Switzerland and United States | Randomized trial | Fifth MC; neck fracture | 68 | BS | 4 mo | Mean: 30 | 97 |
| Casting | Mean: 27 | 96 | ||||||
| Winter et al, 2007 | France | Randomized trial | Fifth MC; neck fracture | 36 | AIMP | 90 d | Mean: 31 (range, 18–65) | NR |
| TP | Mean: 32 (range, 20–49) | NR | ||||||
| Wong et al, 2006 | China | Observational cohort | Fifth MC; neck fracture | 59 | AIMP | Mean: 24 mo (range, 12–36 mo) | Mean: 22 (range, 15–35) | 90 |
| TP | Mean: 23 (range, 14–30) | 93 | ||||||
| Zemirline et al, 2014 | France | Observational cohort | Fifth MC; neck fracture | 56 | AIMP | Mean: 3 mo | Mean: 34 (range, 18–73) | 85 |
| Plating | Mean: 5 mo | Mean: 30 (range, 18–53) | 94 | |||||
| Blocked TP | Mean: 3 mo | Mean: 24 (range, 13–52) | 83 | |||||
| Zhu et al, 2017 | China | Observational cohort | Fifth MC; neck fracture | 96 | Plating | 12 mo | Mean: 36 | 63 |
| Retrograde cross-pinning and plating | Mean: 36 | 64 |
IM, intramedullary; MC, metacarpal; NR, not reported.
Effect Estimates for All Pairwise Comparisons
| Outcome | Comparison | MD or RR (95% CrI) |
|---|---|---|
| Pain, 0–100 (≤ 3 mo) | AIMP vs FB | MD = –0.41 (–22.98 to 21.95) |
| Pain, 0–100 > 3 mo | AIMP vs FB | MD = –0.71 (–6.79 to 5.32) |
| Function, 0–100 ≤ 3 mo | AIMP vs FB | MD = 36.10 (–33.02 to 104.46) |
| Function, 0–100 > 3 mo | AIMP vs BS | MD = –3.97 (–19.97 to 12.00) |
| Time to return to work or regular activities, wk | AIMP vs BS | MD = 8.16 (–5.40 to 22.59) |
| Time to clinical or radiographic union, wk | AIMP vs plating | MD = 1.28 (–0.77 to 3.36) |
| Risk for delayed union | TP vs AIMP | RR = 0.00 (0.00 to 0.76) |
| Risk for implant migration | Plating vs AIMP | RR = 0.00 (0.00 to 0.06) |
| Risk for neurological event | Plating vs AIMP | RR = 0.00 (0.00 to 0.14) |
RR, risk ratio.
Statistically significant.
Figure 2Mean differences in pain scores (scale of 0–100; lower scores represent less pain) between A AIMP, FB, and RIMP at 3 months or less; and B AIMP, FB, plating, RCP, RIMP, and TP at greater than 3 months.
Figure 3Mean differences in functional scores (scale of 0–100; higher scores represent improved function) between A AIMP, FB, RIMP, and SC at 3 months or less; and B AIMP, BS, FB, plating, RCP, RCP-P, RIMP, TP, and SC at greater than 3 months.
Figure 4Mean differences in time to return to work or regular activities (measured in weeks) among AIMP, BS, FB, plating, SC, and TP.
Figure 5Mean differences in time to clinical or radiographic union (measured in weeks) among AIMP, plating, and TP
Figure 6Relative risk for delayed union among AIMP, TP, and plating.
Figure 7Relative risk for implant migration among AIMP, plating, and TP.
Figure 8Relative risk for neurological event among AIMP, plating, and TP.
Study Quality Assessment
| Study, date | Design | Cohort | Control or Comparison Group | Pre-Post Intervention Data | Random Assignment | Random Selection | Follow-Up Rate ≥ 80% | Equivalent Demographics | Equivalent at Baseline on Outcome Measures |
|---|---|---|---|---|---|---|---|---|---|
| Cepni et al, 2016 | RCT | Yes | Yes | Yes | Yes | Yes | Yes | NR | NR |
| Facca et al, 2010 | Obs. | Yes | Yes | Yes | No | Yes | Yes | Yes | NR |
| Fujitani et al, 2012 | Obs. | Yes | Yes | Yes | No | Yes | Yes | Yes | NR |
| Galal and Safwat, 2017 | RCT | Yes | Yes | Yes | Yes | Yes | No | Yes | NR |
| Kaynak et al, 2019 | Obs. | Yes | Yes | Yes | No | Yes | No | Yes | NR |
| Kim and Kim, 2015 | RCT | Yes | Yes | Yes | Yes | Yes | Yes | Yes | NR |
| Schadel-Hopfner et al, 2007 | Obs. | Yes | Yes | Yes | No | Yes | Yes | Yes | NR |
| Sletten et al, 2015 | RCT | Yes | Yes | Yes | Yes | Yes | Yes | Yes | NR |
| Strub et al, 2010 | RCT | Yes | Yes | Yes | Yes | Yes | Yes | Yes | NR |
| van Aaken et al, 2016 | RCT | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes |
| Winter et al, 2007 | RCT | Yes | Yes | Yes | Yes | Yes | Yes | Yes | NR |
| Wong et al, 2006 | Obs. | Yes | Yes | Yes | No | Yes | NR | Yes | NR |
| Zemirline et al, 2014 | Obs. | Yes | Yes | Yes | No | Yes | NR | Yes | NR |
| Zhu et al, 2017 | Obs. | Yes | Yes | Yes | No | Yes | NR | Yes | NR |
NR, not reported; Obs., observational cohort.